• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从社会角度看德国失明和视力损害的经济负担:疾病成本研究。

Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study.

机构信息

Center for Health Economics and Health Services Research, Schumpeter School of Business and Economics, University of Wuppertal, Rainer-Gruenter-Str. 21, 42119, Wuppertal, Germany.

Department of Ophthalmology, University of Bonn, Ernst-Abbe-Str. 2, 53127, Bonn, Germany.

出版信息

Eur J Health Econ. 2020 Feb;21(1):115-127. doi: 10.1007/s10198-019-01115-5. Epub 2019 Sep 6.

DOI:10.1007/s10198-019-01115-5
PMID:31493181
Abstract

BACKGROUND

Visual impairment and blindness cause a considerable and increasing economic burden affecting not only persons with vision loss and their families, but also societies. For the majority of countries, there is no solid database that would allow a comprehensive assessment of costs from a societal perspective. The present study was conducted to fill this gap.

OBJECTIVES

To investigate resource utilization of blind or visually impaired people and to assess the economic burden of blindness and visual impairment in Germany.

METHODS

This cross-sectional cost-of-illness study measures the economic burden of blindness and visual impairment bottom-up and from a societal perspective. Therefore, blind and visually impaired persons were recruited via national self-help organizations (prevalence-based approach) and interviewed regarding their utilized resources using various survey modes (mixed-mode approach). The observation period was 6 months retrospectively. Utilized resources were valued applying standardized unit costs (macro-costing). Calculations for the study population provided direct and indirect costs per person for a period of 6 months. Further cost per category was extrapolated to 1 year for the general population of Germany. Uncertainty of results was addressed applying univariate deterministic sensitivity analyses.

RESULTS

Complete data were collected from 683 participants (54.84% women; average age: 60.28 ± 17.02 years). Decreasing vision was associated with increasing costs (p < 0.001). Most costs were incurred by informal support from relatives, which was the most important resource for coping with everyday life for people with visual loss. Together with assistive/medical devices and loss of productivity due to disability, informal support accounted for 80% of total costs. Extrapolated to Germany, the annual costs of blindness and visual impairment from a societal perspective amounted to € 49.6 billion. Results of the sensitivity analyses and 95% confidence intervals showed a considerable degree of uncertainty.

CONCLUSION

Visual impairment and blindness may cause enormous overall costs from a societal point of view, as shown here for Germany. Our findings on the costs of blindness and visual impairment in Germany add in a number of different ways to the international evidence. In particular, results show that a large proportion of the costs are not obvious per se as it is caused by self-paid deductibles, productivity loss, early retirement and informal support/care by relatives. Further research should make special efforts to investigate these costs precisely as well as their influence factors.

摘要

背景

视力障碍导致相当大且不断增加的经济负担,不仅影响视力受损者及其家庭,也影响社会。对于大多数国家来说,没有一个坚实的数据库可以从社会角度全面评估成本。本研究旨在填补这一空白。

目的

调查盲或视力障碍者的资源利用情况,并评估德国盲和视力障碍的经济负担。

方法

本研究采用患病成本法,从社会角度对盲和视力障碍者进行横断面研究。为此,通过国家自助组织(基于患病率的方法)招募盲人和视力障碍者,并通过各种调查模式(混合模式方法)对其使用的资源进行访谈。观察期为 6 个月回溯期。使用的资源采用标准化单位成本进行评估(宏观成本核算)。根据研究人群的计算结果,为 6 个月期间的每个人提供直接和间接成本。进一步将每个类别的成本推算到德国一般人群的 1 年。使用单变量确定性敏感性分析解决结果的不确定性。

结果

共收集到 683 名参与者(54.84%为女性;平均年龄:60.28±17.02 岁)的完整数据。视力下降与成本增加相关(p<0.001)。最大的成本来自于亲属的非正规支持,这是非视力受损者日常生活应对中最重要的资源。与辅助/医疗设备和因残疾导致的生产力损失一起,非正规支持占总成本的 80%。从社会角度推算,德国盲和视力障碍的年度成本为 496 亿欧元。敏感性分析和 95%置信区间的结果显示存在相当大的不确定性。

结论

从社会角度来看,视力障碍可能导致巨大的总体成本,德国的情况就是如此。本研究关于德国盲和视力障碍成本的发现以多种不同方式补充了国际证据。特别是,研究结果表明,很大一部分成本本身并不明显,因为这是由自费免赔额、生产力损失、提前退休和亲属的非正规支持/护理造成的。进一步的研究应该特别努力准确地调查这些成本及其影响因素。

相似文献

1
Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study.从社会角度看德国失明和视力损害的经济负担:疾病成本研究。
Eur J Health Econ. 2020 Feb;21(1):115-127. doi: 10.1007/s10198-019-01115-5. Epub 2019 Sep 6.
2
Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.双侧新生血管性年龄相关性黄斑变性的经济负担:多国观察性研究。
Pharmacoeconomics. 2008;26(1):57-73. doi: 10.2165/00019053-200826010-00006.
3
Economic impact of visual impairment and blindness in the United States.美国视力损害和失明的经济影响。
Arch Ophthalmol. 2007 Apr;125(4):544-50. doi: 10.1001/archopht.125.4.544.
4
[Social costs of visual handicap and blindness. Rehabilitation resources for blind patients].[视力障碍与失明的社会成本。盲人患者的康复资源]
Klin Monbl Augenheilkd. 1992 Dec;201(6):370-4. doi: 10.1055/s-2008-1045914.
5
The Economic Burden of Visual Impairment and Comorbid Fatigue: A Cost-of-Illness Study (From a Societal Perspective).视觉障碍与共病性疲劳的经济负担:一项疾病成本研究(从社会角度来看)。
Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):1916-1923. doi: 10.1167/iovs.17-23224.
6
The economic burden of vision loss and eye disorders among the United States population younger than 40 years.美国 40 岁以下人群中视力丧失和眼部疾病的经济负担。
Ophthalmology. 2013 Sep;120(9):1728-35. doi: 10.1016/j.ophtha.2013.01.068. Epub 2013 Apr 28.
7
Societal costs of multiple sclerosis in Ireland.爱尔兰多发性硬化症的社会成本。
J Med Econ. 2018 May;21(5):425-437. doi: 10.1080/13696998.2018.1427100. Epub 2018 Feb 7.
8
Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK.四个欧洲国家(法国、意大利、德国和英国)与视力障碍相关的非医疗成本评估。
Pharmacoeconomics. 2006;24(2):193-205. doi: 10.2165/00019053-200624020-00007.
9
Costs and quality of life of multiple sclerosis in Austria.奥地利多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S14-23. doi: 10.1007/s10198-006-0382-x.
10
Humanistic and Economic Burden of Blindness Associated with Retinal Disorders in a Brazilian Sample: A Cross-Sectional Study.巴西人群中视网膜疾病相关盲的人文和经济负担:一项横断面研究。
Adv Ther. 2021 Aug;38(8):4215-4230. doi: 10.1007/s12325-021-01672-3. Epub 2021 Mar 31.

引用本文的文献

1
Interaction between native and prosthetic visual responses in optogenetic visual restoration.光遗传学视觉恢复中天然视觉反应与假体视觉反应之间的相互作用。
JCI Insight. 2025 Apr 15;10(11). doi: 10.1172/jci.insight.190785. eCollection 2025 Jun 9.
2
Risk of visual impairment according to the comorbidity of systemic and ocular diseases.根据系统性疾病和眼部疾病的合并症,发生视力障碍的风险。
PLoS One. 2024 Sep 5;19(9):e0307011. doi: 10.1371/journal.pone.0307011. eCollection 2024.
3
Assessing the economic burden of vision loss and irreversible legal blindness in Spain (2021-2030): a societal perspective.

本文引用的文献

1
[Self-reported vision in (gerontological) health services research and practice-an opening plea].[(老年医学)健康服务研究与实践中的自我报告视力——开篇呼吁]
Ophthalmologe. 2018 Oct;115(10):818-825. doi: 10.1007/s00347-018-0704-2.
2
The economic impact of sight loss and blindness in the UK adult population.视力丧失和失明对英国成年人口的经济影响。
BMC Health Serv Res. 2018 Jan 30;18(1):63. doi: 10.1186/s12913-018-2836-0.
3
Modeling Health Care Expenditures and Use.建模医疗保健支出和使用。
评估西班牙视力丧失和不可逆法定失明的经济负担(2021 - 2030年):社会视角
Health Econ Rev. 2024 Sep 3;14(1):70. doi: 10.1186/s13561-024-00546-y.
4
Impact of Social Vulnerability Index on the Development of Severe Visual Impairment or Blindness From Glaucoma.社会脆弱性指数对青光眼致严重视力损害或失明的影响。
Am J Ophthalmol. 2024 Nov;267:172-181. doi: 10.1016/j.ajo.2024.06.024. Epub 2024 Jul 4.
5
Technological Perception with Rural and Urban Differentiation and Its Influence on the Quality of Life of Older People with Age-Related Macular Degeneration.城乡差异下的技术认知及其对老年黄斑变性患者生活质量的影响
Eur J Investig Health Psychol Educ. 2024 May 20;14(5):1470-1488. doi: 10.3390/ejihpe14050097.
6
Economic evaluation for medical artificial intelligence: accuracy vs. cost-effectiveness in a diabetic retinopathy screening case.医学人工智能的经济评估:糖尿病视网膜病变筛查案例中的准确性与成本效益
NPJ Digit Med. 2024 Feb 21;7(1):43. doi: 10.1038/s41746-024-01032-9.
7
Typologies of dependency, household characteristics, and disparity in formal and informal care use: analysis of community-dwelling long-term care insurance claimants in an urban municipality of China.依赖类型、家庭特征与正规和非正规照料使用的差距:对中国一城市社区长期护理保险参保者的分析。
Int J Equity Health. 2023 Nov 10;22(1):235. doi: 10.1186/s12939-023-02048-5.
8
[Awareness for glaucoma in the general population].[普通人群对青光眼的认知情况]
Ophthalmologie. 2023 Nov;120(11):1088-1097. doi: 10.1007/s00347-023-01943-0. Epub 2023 Oct 17.
9
Trends in the Prevalence of Blindness and Correlation With Health Status in Korean Adults: A 10-Year Nationwide Population-Based Study.韩国成年人失明患病率趋势及与健康状况的相关性:一项为期 10 年的全国人口为基础的研究。
J Korean Med Sci. 2023 Jul 17;38(28):e213. doi: 10.3346/jkms.2023.38.e213.
10
Cost-effectiveness analysis of myopia management: A systematic review.近视管理的成本效益分析:系统综述。
Front Public Health. 2023 Feb 27;11:1093836. doi: 10.3389/fpubh.2023.1093836. eCollection 2023.
Annu Rev Public Health. 2018 Apr 1;39:489-505. doi: 10.1146/annurev-publhealth-040617-013517. Epub 2018 Jan 12.
4
[Evaluation of the medical treatment situation of the visually impaired : Significant differences between young and old].视障人士医疗状况评估:年轻人与老年人之间的显著差异
Ophthalmologe. 2019 Feb;116(2):164-171. doi: 10.1007/s00347-017-0643-3.
5
The Economic Impact of Blindness in Europe.欧洲失明问题的经济影响。
Ophthalmic Epidemiol. 2017 Aug;24(4):239-247. doi: 10.1080/09286586.2017.1281426. Epub 2017 Jun 30.
6
Study protocol of the German Study on Tobacco Use (DEBRA): a national household survey of smoking behaviour and cessation.德国烟草使用研究(DEBRA)的研究方案:一项关于吸烟行为与戒烟的全国家庭调查。
BMC Public Health. 2017 May 2;17(1):378. doi: 10.1186/s12889-017-4328-2.
7
Early health economic evaluation of the future potential of next generation artificial vision systems for treating blindness in Germany.下一代人工视觉系统治疗失明的未来潜力在德国的早期健康经济评估。
Health Econ Rev. 2014 Dec;4(1):27. doi: 10.1186/s13561-014-0027-1. Epub 2014 Nov 1.
8
Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study.日本糖尿病视网膜病变筛查的成本效用分析:一项概率性马尔可夫模型研究。
Ophthalmic Epidemiol. 2015 Feb;22(1):4-12. doi: 10.3109/09286586.2014.988876. Epub 2014 Dec 17.
9
[Calculation of standardised unit costs from a societal perspective for health economic evaluation].从社会角度进行卫生经济评估的标准化单位成本计算
Gesundheitswesen. 2015 Jan;77(1):53-61. doi: 10.1055/s-0034-1374621. Epub 2014 Jul 15.
10
[Macroeconomic costs of eye diseases].[眼科疾病的宏观经济成本]
Ophthalmologe. 2014 May;111(5):420-7. doi: 10.1007/s00347-013-2921-z.